41O Intrinsic Valuation and Fundamental Analysis - Outlook Therapeutics Inc

	Outlook Therapeutics Inc F:41O	US

Intrinsic Value

The intrinsic value for Outlook Therapeutics Inc (41O) under the Base Case is 0.444 EUR. Compared with the current market price of 0.847 EUR, the stock appears Overvalued by 48% .

Intrinsic value calculated using Multiples

€0.444

Other reference points

Wall St target

€3.718

Do our valuations actually work? See backtest results .

41O Intrinsic Value

Overvaluation 48%

Intrinsic Value

Price €0.847

Track Buy Zone

20% below Intrinsic Value €0.36

Get notified when the price drops into your buy zone

Current Price €0.85

Intrinsic Value €0.44

Margin of Safety 20% €0.36

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Outlook Therapeutics Inc.

Explain Valuation